Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer’s disease: the Altoida large cohort study

Abstract Conventional neuropsychological assessments for Alzheimer’s disease are burdensome and inaccurate at detecting mild cognitive impairment and predicting Alzheimer’s disease risk. Altoida’s Digital Neuro Signature (DNS), a longitudinal cognitive test consisting of two active digital biomarker...

Full description

Saved in:
Bibliographic Details
Main Authors: Irene B. Meier, Max Buegler, Robbert Harms, Azizi Seixas, Arzu Çöltekin, Ioannis Tarnanas
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Online Access:https://doaj.org/article/8ad6563ddcef480eb7e920b165677cf6
Tags: Add Tag
No Tags, Be the first to tag this record!